MALDI-TOF
BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System
The next-generation system, which received CE marking last year, identifies bacteria more rapidly and is now commercially available in the US.
Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test
The company's RT-PCR/MALDI-TOF test comprises five assays designed to detect the N, ORF1, and ORF1ab regions of the SARS-CoV-2 genome.
MALDI-TOF, Rapid Molecular Testing Strategy Fuel Outreach Growth for Cayuga Medical Center Lab
Premium
Since moving to rapid molecular testing, the lab has doubled its billable test volume, largely through increasing clients for its outreach lab services.
Lab director Glenn George discusses trends within clinical microbiology that could set it apart from other portions of the clinical laboratory.
The method could allow clinicians to more rapidly determine the best course of antibiotic treatment for patients with sepsis and other bacterial infections.
Aug 1, 2018